| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 17.440 | 20101214, Gadisseur R
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 4.290 | 20100301, Scala E
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 15.800 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 8.570 | 20130605, Simon D
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 28.130 | 20120528, Patelis A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 17.860 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 55.000 | 20091005, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 4.000 | 20140821, Choi JS
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 3.700 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 3.1.1 - Source Sensitized (SPT) | 1997 | Netherlands | IgE | 19 | 78.900 | | | 3.2.1 - Source Sensitized (IgE) | 2006 | Japan | IgE | 20 | 40.000 | 20061127, Kamata Y
| | 3.2.1 - Source Sensitized (IgE) | 2010 | Sweden | IgE | 89 | 67.000 | 20100719, Madhurantakam C
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 27.270 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 15.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 24.320 | 20090826, Ebo DG
| | 5.2.4 - Source Exposed, Adults (Symptoms, IgE) | 2012 | Sweden | IgE | 100 | 55.000 | 20120420, Nilsson OB
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 21.210 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2007 | Finland | IgE | 31 | 42.000 | 20071207, Saarelainen S
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Spain / Sweden / USA | IgE | 37 | 48.650 | 20100609, Mattsson L
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 100 | 43.000 | 20141030, Nilsson OB
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 37 | 30.000 | 20140127, Konradsen JR
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 28 | 21.000 | 20140127, Konradsen JR
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Sweden | IgE | 37 | 48.640 | 20090109, Mattsson L
| | 5.4.2 - Source Exposed (Symptoms, SPT, high IgE) | 2004 | Finland | IgE | 25 | 44.000 | | | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 2.430 | 20120528, Patelis A
| | 5.4.2 - Source Exposed (Symptoms, SPT, high IgE) | 2004 | Finland | IgE (IB) | 25 | 52.000 | | | 5.4.2 - Source Exposed (Symptoms, SPT, high IgE) | 2004 | Finland | SPT | 25 | 52.000 | |
|
Loading...
Can f 1
